Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

  • There is currently no data for MSYS

Update on Financing, GM & Prospective Acquisition

14 Dec 2023 07:00

RNS Number : 7198W
Microsaic Systems plc
14 December 2023
 

14 December 2023

Microsaic Systems plc("Microsaic" or the "Company")

 

Update on Financing and General MeetingProspective Acquisition

 

Capitalised terms in this announcement carry the same meaning as in the RNS dated 4 December 2023 unless the context indicates otherwise

Further to the Company's announcement on 4 December 2023 regarding the publication of the Circular to convene the General Meeting to approve resolutions to enable the Company, inter alia, to complete the Fundraising, Microsaic provides the following update:

The Company has been evaluating a prospective acquisition opportunity (the "Acquisition") which, in the Directors' view, has considerable merit and would enhance the prospects for the enlarged group. The Acquisition opportunity is expected to support a larger fundraising to facilitate the continuation and initial subsequent growth of the enlarged group (the "Revised Fundraising"). The Company expects to provide a further update in the coming days, to enable Shareholders to understand the effects of the Acquisition on the Company and the prospects for the enlarged group, and also to update the expected timetable of principal events described in the Circular (which may include a deferral of the date by which Admission of the Fundraising Shares has to become effective).

Recognising that Shareholders must be provided with all information necessary to allow members to make a properly informed decision when considering voting resolutions, the Company proposes to open the General Meeting and then immediately adjourn it to on or around 27 December 2023, noting that no business shall be dealt with at such adjourned meeting, the general nature of which was not stated in the notice of the original General Meeting. The Company has realised a small amount of cash to enable it to extend its cash runway through December, and will continue to target completion of the Revised Fundraising (at a higher minimum than defined in the Circular) and completion of the Acquisition on or around the end of this calendar year.

Additional information on the Acquisition and the Revised Fundraising will be provided in a further announcement expected in the coming days. At this time there is no guarantee that the Acquisition will be completed, but the Company will seek to a period of exclusivity to enable it to secure commitments for the Revised Fundraising. The net proceeds of the Revised Fundraising will support the working capital needs of the enlarged group as well as the consideration for the Acquisition, which would be structured as an asset purchase. During such period of exclusivity, the Company would seek to conclude due diligence on the Acquisition and negotiate terms of an Asset Purchase Agreement, before seeking restoration of admission to trading on AIM and completion of both the Revised Fundraising and the Acquisition, subject still to the conditions outlined in the Circular as well as other customary completion items for an asset purchase. An alternative resolution for Cancellation is still likely to be put to the General Meeting in case the Fundraising or the Revised Fundraising and Acquisition do not complete.

 

Information for Shareholders:

Shareholders wishing to revoke an existing voting instruction should follow the process described in the Notice. The helpline number given in the notes to the Notice remains available to Shareholders and may be used to request a fresh proxy voting form if the original has already been used.

 

Enquiries:

Microsaic Systems plc

Bob MooreExecutive Chairman

+44 (0)1483 751 577

Singer Capital Markets(Nominated Adviser)

+44 (0)20 7496 3000

Aubrey Powell / Angus Campbell

 

 

Turner Pope Investments (TPI) Limited

(Broker)

Andy Thacker / James Pope

+44 (0) 20 3657 0050

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDGZMMZFFFGFZZ
Date   Source Headline
24th Nov 20222:00 pmRNSPrice Monitoring Extension
30th Sep 20227:00 amRNSHalf-year Report
13th Sep 20227:25 amRNSSupply of mass spectroscopy services to DeepVerge
22nd Aug 20227:00 amRNSPartnership with Kingfield Electronics
5th Jul 20224:41 pmRNSSecond Price Monitoring Extn
5th Jul 20224:35 pmRNSPrice Monitoring Extension
5th Jul 20222:06 pmRNSSecond Price Monitoring Extn
5th Jul 20222:01 pmRNSPrice Monitoring Extension
4th Jul 20224:43 pmRNSReplacement: Trading Update
1st Jul 20222:09 pmRNSHolding(s) in Company
30th Jun 202212:11 pmRNSResult of AGM
30th Jun 20227:00 amRNSTrading Update
1st Jun 20227:00 amRNSPosting of Annual Report & Notice of AGM
30th May 20227:00 amRNSFinal Results
19th Apr 20227:00 amRNSManufacturing Services Framework Agreement
28th Mar 20227:30 amRNSUpdate on Microsaic's miniaturised technology
15th Mar 20227:00 amRNSBoard Appointment and Strategic Update
8th Mar 20224:35 pmRNSPrice Monitoring Extension
7th Mar 20222:05 pmRNSSecond Price Monitoring Extn
7th Mar 20222:00 pmRNSPrice Monitoring Extension
21st Feb 20221:31 pmRNSHolding(s) in Company
17th Feb 20222:45 pmRNSHolding(s) in Company
16th Feb 202211:06 amRNSSecond Price Monitoring Extn
16th Feb 202211:00 amRNSPrice Monitoring Extension
14th Feb 20227:00 amRNSDirector Dealing, Issue of Equity and TVR
28th Jan 20227:00 amRNSResignation of Chief Executive Officer
12th Jan 20224:43 pmRNSHolding(s) in Company
10th Jan 20223:30 pmRNSInvestor Presentation
10th Jan 20227:00 amRNSTrading Update
7th Jan 20222:06 pmRNSSecond Price Monitoring Extn
7th Jan 20222:00 pmRNSPrice Monitoring Extension
13th Dec 20217:00 amRNSFurther order from DeepVerge
12th Nov 20217:00 amRNSNew compact screening platform
5th Nov 202110:12 amRNSHolding(s) in Company
27th Oct 20217:00 amRNSLaunch of technology for scaling drug manufacture
22nd Oct 20217:00 amRNSBoard Change
21st Oct 20217:00 amRNSUpdate on DeepVerge Collaboration
28th Sep 20214:30 pmRNSHolding(s) in Company
27th Sep 20217:00 amRNSInterim Results
24th Sep 20217:00 amRNSSigning of agreement to support China operations
22nd Sep 202111:06 amRNSNotice of Results and Investor Presentation
27th Aug 20214:40 pmRNSSecond Price Monitoring Extn
27th Aug 20214:35 pmRNSPrice Monitoring Extension
23rd Aug 20217:00 amRNSDeepVerge Collaboration for Water & Soil Analysis
9th Aug 20217:00 amRNSHeads of Terms signed with manufacturer in China
6th Jul 202111:55 amRNSInvestor Presentation
6th Jul 20217:00 amRNSTrading update for H1 2021
5th Jul 20219:50 amRNSHolding(s) in Company
2nd Jul 20217:00 amRNSDevelopment of real-time monitoring solution
17th Jun 202110:54 amRNSResult of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.